The Novel Sglt-2 Inhibitor, Empagliflozin, Prevents Pioglitazone-Induced Weight Gain And Further Improves Glycaemic Control In Dietary-Induced Obese Rats
DIABETIC MEDICINE(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
DIABETIC MEDICINE(2014)